CA 19–9 predicts resectability of pancreatic cancer even in jaundiced patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CA 19–9 predicts resectability of pancreatic cancer even in jaundiced patients

Published:2018-09 Issue:6 Volume:18 Page:666-670
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

Santucci Nicolas,Facy Olivier,Ortega-Deballon Pablo,Lequeu Jean-Baptiste,Rat Paul,Rat Patrick

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference32 articles.

1. Rising incidence of pancreatic cancer in France;Bouvier;Pancreas,2010

2. Pancreatic adenocarcinoma: the actual 5-year survivors;Ferrone;J Gastrointest Surg,2008

3. Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature;Garcea;JOP J Pancreas,2008

4. Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation;Bluemke;Radiology,1995

5. Local staging of pancreatic carcinoma with multi-detector row CT: use of curved planar reformations initial experience;Prokesch;Radiology,2002

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traditional Biomarkers in Patients with Pancreatic Cancer Staged by Computed Tomography and Endoscopic Ultrasound: Is There Still a Role in the Molecular Era?;Gastrointestinal Disorders;2024-08-07

2. Differential impact of incrementally elevated CA 19-9 levels on prognosis of resected pancreatic ductal adenocarcinoma;HPB;2024-06

3. Can preoperative Carbohydrate Antigen 19-9 predict metastatic pancreatic cancer? Results of a systematic review and meta-analysis;HPB;2024-05

4. Tumor Size Combined With CA-19 Level Improves Prediction of Survival of Patients With Pancreatic Adenocarcinoma Undergoing Perioperative Chemotherapy and Resection;The American Surgeon™;2024-03-21

5. Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer;Annals of Hepato-Biliary-Pancreatic Surgery;2024-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3